Company Filing History:
Years Active: 1985-1989
Title: The Innovative Contributions of Robert F. Baugh
Introduction
Robert F. Baugh is a notable inventor based in Aurora, Colorado, recognized for his significant contributions to the field of medical technology. He holds three patents that focus on improving blood sample collection and analysis, particularly in the context of heparin therapy. His work has the potential to enhance patient care and outcomes in clinical settings.
Latest Patents
Baugh's latest patents include a method for collecting and analyzing a sample of blood when monitoring. This method incorporates an inhibitor of platelet-related procoagulant activity in the collection medium, which prevents an initial drop in the recalcified activated clotting time during assay tests. This discovery addresses a critical issue in heparin therapy, where the initial drop in activated clotting time can be substantial. Additionally, he has developed a collection medium for whole blood that includes an inhibitor of Platelet Factor 3 activity. This innovation also aims to prevent the initial drop in activated clotting time, further emphasizing its importance in heparin therapy.
Career Highlights
Baugh's career is marked by his dedication to advancing medical technology through innovative solutions. His work at Hemotec, Inc. has positioned him as a key player in the development of blood collection methods that enhance the accuracy and reliability of laboratory results. His patents reflect a deep understanding of the complexities involved in blood sample analysis and the need for improved methodologies.
Collaborations
Throughout his career, Baugh has collaborated with esteemed colleagues, including Cynthia A. Taylor and Walter Jacob Braun. These partnerships have contributed to the successful development and implementation of his innovative ideas.
Conclusion
Robert F. Baugh's contributions to medical technology through his patents demonstrate his commitment to improving patient care. His innovative methods for blood sample collection and analysis are poised to make a significant impact in the field of heparin therapy.